BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15572854)

  • 21. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
    Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.
    Santos SB; Oliveira P; Luna T; Souza A; Nascimento M; Siqueira I; Tanajura D; Muniz AL; Glesby MJ; Carvalho EM
    J Med Virol; 2012 Nov; 84(11):1809-17. PubMed ID: 22997085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
    Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
    PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
    Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S
    Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cytokines, neurological disability, and disease duration in HAM/TSP patients.
    Muniz AL; Rodrigues W; Santos SB; de Jesus AR; Porto AF; Castro N; Oliveira-Filho J; Almeida JP; Moreno-Carvalho O; Carvalho EM
    Arq Neuropsiquiatr; 2006 Jun; 64(2A):217-21. PubMed ID: 16791359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
    Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
    J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-1 induces a Th1-like state in CD4
    Yamano Y; Coler-Reilly A
    J Neuroimmunol; 2017 Mar; 304():51-55. PubMed ID: 27542993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
    Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
    Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
    J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.